BUZZ-U.S. STOCKS ON THE MOVE-Acadia Pharma, Verint, Lululemon, Valeant
(For faster updates on individual market-movers, Eikon users please use search string "STXBZ US"; for the Day Ahead newsletter, link.reuters.com/mex49s; for the Morning News Call newsletter, link.reuters.com/nex49s) U.S. stock index futures were higher on Wednesday, a day after comments by Federal Reserve Chair Janet Yellen allayed concerns that the central bank would take an aggressive approach to raising interest rates this year. Dow Jones industrial average futures were up 0.60 percent at 17,644, S&P 500 futures were up 0.60 percent at 2,059.75 and Nasdaq 100 futures were up 0.78 percent at 4,493.
** ACADIA PHARMACEUTICALS INC, Tuesday close $23.81, +24.53 pct premarket
An advisory panel to the U.S. Food and Drug Administration backed an approval for Acadia Pharmaceuticals' drug for psychosis related to Parkinson's disease.
** VERINT SYSTEMS INC, Tuesday close $35.19, -13.98 pct premarket
The data analytics company reported lower-than-expected Q4 revenue and profit, hurt by weakness in its security intelligence business.
** LULULEMON ATHLETICA INC, Tuesday close $61.24, +6.12 pct premarket Continued...